CRP-Test als Biomarker für kardiovaskuläres Risiko?

Literatur

• 1 Koenig W, Hoffmeister A, Khuseyinova N. et al . Atherosklerose als inflammatorischer Prozess: C-reaktives Protein und koronares Risiko.  Dtsch Ärztebl. 2003;  100 A117-126
• 2 Ridker P M, Buring J M, Cook N R. et al . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14 719 initially healthy American women.  Circulation. 2003;  107 391-397
• 3 Tehernof A, Nolan A, Sites C T. et al . Weight loss reduces C-reactive protein levels in obese postmenopausal women.  Circulation. 2002;  105 564-569
• 4 Fröhlich M, Imhof A, Berg G. et al . Association between C-reactive protein and features of the metabolic syndrome.  Diabetes Care. 2000;  23 1835-1839
• 5 Danesh J, Wheeler J G, Hirschfield G M. et al . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.  N Engl J Med. 2004;  350 1387-1397
• 6 Pai J K, Pischon T, Ma J. et al . Inflammatory markers and the risk of coronary heart disease in men and women.  N Engl J Med.. 2004;  351 2599-2610
• 7 Linnemann B, Voigt W, Nobel W. et al . C-reactive Protein is a strong independent predictor of death in Type 2 Diabetes: Association with multiple facets of the metabolic syndrome.  Exp Clin Endocrinol Diabetes. 2006;  114 127-134
• 8 Rothenbacher D, Brenner H, März W. et al . Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.  Eur Heart J. 2005;  26 1640-1646
• 9 Koenig W, Meisinger C, Baumert J. et al . Systemic low-grade inflammation and risk of coronary heart disease: Results from the MONICA/KORA Augsburg Cohort Studies.  Gesundheitswesen. 2005;  67 (Suppl.1) 62-67